Access in Qatar

Middle East ยท Tier 2

Regulatory framework

Qatar's MoPH permits unregistered drug import under a named-patient pathway with physician and MoPH approval; Hamad Medical Corp frequently sponsors.

Case active and ready to skip the regulatory walkthrough? Ask about a medicine or WhatsApp us.

Typical timeline

We give you a written timeline estimate for your case before you commit. Timing depends on the specific drug, the clinical justification, and destination-regulator review pace.

What a typical process looks like

  1. Patient or physician submits a request with drug name and indication.
  2. We verify clinical appropriateness and document eligibility.
  3. Treating physician issues prescription and clinical justification.
  4. Country-specific regulatory documentation is prepared and submitted.
  5. Patient pre-pays; we source via DSCSA-compliant US wholesaler.
  6. Drug ships cold-chain to destination physician or hospital pharmacy.
  7. Physician receives, confirms storage, and begins treatment.

Popular drug requests from Qatar

Lenmeldy

Metachromatic leukodystrophy

Kresladi

Leukocyte adhesion deficiency I

Elevidys

Duchenne muscular dystrophy

Lyfgenia

Sickle cell disease

Zevaskyn

Recessive DEB

Skysona

Cerebral adrenoleukodystrophy

Casgevy

Sickle cell disease; transfusion-dependent beta-thalassemia

Ryoncil

Pediatric SR-aGvHD

Tecelra

Synovial sarcoma

Encelto

Macular telangiectasia type 2

Qfitlia

Hemophilia A/B prophylaxis

Vyjuvek

Dystrophic epidermolysis bullosa

Review & oversight. Content on this page is reviewed by the Reserve Meds clinical operations team. Your treating doctor's prescription is verified before anything ships. Regulatory information on this site is general information, not legal advice. Review methodology ›
Last medically reviewed: .
WhatsApp